Research Wilmot Plays Role in Latest FDA-Approved CLL Therapy Feb. 13, 2014 Facebook Twitter LinkedIn Email Skip breadcrumb URMC Home Newsroom News Wilmot Plays Role in Latest FDA-Approved CLL Therapy